This seminar will examine the future for cancer care in Wales, with the Wales Cancer Delivery Plan due to conclude next year.
Taking place at an important stage in the delivery of the Plan itself, delegates will examine the lessons learnt from its implementation.
The conference also discusses the introduction of the Single Suspected Cancer Pathway (SSCP) - which aims to ensure all patients begin treatment within 62 days of the point of suspicion.
Delegates will assess the options for policy post-2020, with discussion expected on the potential development of a new plan and integration into wider policy documents such as Healthier Wales.
Issues for consideration include how any strategy can support improvements in treatment, care and resource-efficiency looking at approaches such as better use of data, diagnostic screening and access to cutting-edge medicines and biosimilars, as well as how services can be aligned with the latest research and the provision of a holistic approach to care.
Further sessions look forward to implementation of the Delivery Plan in the remainder of its timeframe, and opportunities for it to be refreshed and refined to bring it into line with latest thinking.
Delegates will also look at the implementation of the SSCP as it begins, looking at the priorities for diagnostic services, patient involvement, seamless movement through the pathway, the role of research, and optimising performance.
We expect discussion on how to understand what the new measurement means, how the new waiting time targets will be used to evaluate and improve performance, and whether it will lead to more early stage diagnoses.
Attendees will consider workforce capabilities, especially around diagnostic gaps, and the potential impact of training non-specialists and approaches to improving triage to help plug these gaps. It comes as the recent workforce report from the Royal College of Radiologists highlights the falling numbers of clinical oncologists, with Wales being especially adversely affected.
The seminar will also be a chance to consider how Wales can build on the Statement of Intent on advanced and precision therapies, to unlock benefits for patients. Discussion is expected to focus on the need to improve public engagement and understanding of these personalised therapies, and on how new clinical pathways can be developed and streamlined to ensure effective collaboration between industry partners and NHS Wales services.
They will look at improving IT services and the interfaces between primary and secondary care - looking at digitisation of patient data, seeking to ensure effective collaboration and a seamless system for patients - as well as the broader infrastructure needed to meet the waiting times goal.
Further sessions focus on early diagnosis, prevention and public health policy including options for achieving a better understanding of health-seeking behaviours - as well as for improving self-reporting of symptoms and reaching out to forgotten and hidden groups with appropriate targeting of awareness strategies.
The agenda also considers the role of longer term health strategies, especially around obesity, exercise and smoking, to create a culture change that will reduce incidents of cancer.